Immix Biopharma (IMMX) Cash from Operations (2021 - 2026)

Quarterly results put Cash from Operations at 9827193.0 for Q1 2026, down 483.17% from a year ago — trailing twelve months through Mar 2026 was 32072357.0 (down 157.54% YoY), and the annual figure for FY2025 was 23930304.0, down 63.96%.

Immix Biopharma has reported Cash from Operations over the past 6 years, most recently at 9827193.0 for Q1 2026.

  • Cash from Operations reached 9827193.0 in Q1 2026 per IMMX's latest filing, up from 11029607.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 547066.0 in Q2 2022 and bottomed at 11029607.0 in Q4 2025.
  • Median Cash from Operations over the past 5 years was 3515346.0 (2023), compared with a mean of 3948961.18.
  • The largest annual shift saw Cash from Operations plummeted 2781.24% in 2022 before it surged 55.97% in 2025.
  • Over 5 years, Cash from Operations stood at 3903926.0 in 2022, then skyrocketed by 31.42% to 2677437.0 in 2023, then surged by 44.87% to 1476198.0 in 2024, then crashed by 647.16% to 11029607.0 in 2025, then increased by 10.9% to 9827193.0 in 2026.
  • Business Quant data shows Cash from Operations for IMMX at 9827193.0 in Q1 2026, 11029607.0 in Q4 2025, and 5905776.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -1.67 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.43 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 1.08 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 70.50 Mn
10 Immix Biopharma 476.17 Mn 476.17 Mn - -9.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.83 Mn
Mar 31, 2026 -9.83 Mn
Dec 31, 2025 -11.03 Mn
Dec 31, 2025 -11.03 Mn
Sep 30, 2025 -5.91 Mn
Sep 30, 2025 -5.91 Mn
Jun 30, 2025 -5.31 Mn
Jun 30, 2025 -5.31 Mn
Mar 31, 2025 -1.69 Mn
Mar 31, 2025 -1.69 Mn
Dec 31, 2024 -1.48 Mn
Dec 31, 2024 -1.48 Mn
Sep 30, 2024 -4.04 Mn
Sep 30, 2024 -4.04 Mn
Jun 30, 2024 -5.26 Mn
Jun 30, 2024 -5.26 Mn
Mar 31, 2024 -3.83 Mn
Mar 31, 2024 -3.83 Mn
Dec 31, 2023 -2.68 Mn
Dec 31, 2023 -2.68 Mn
Sep 30, 2023 -3.09 Mn
Sep 30, 2023 -3.09 Mn
Jun 30, 2023 -3.52 Mn
Jun 30, 2023 -3.52 Mn
Mar 31, 2023 -2.09 Mn
Mar 31, 2023 -2.09 Mn
Dec 31, 2022 -3.90 Mn
Dec 31, 2022 -3.90 Mn
Sep 30, 2022 -1.46 Mn
Sep 30, 2022 -1.46 Mn
Jun 30, 2022 -547,066.00
Jun 30, 2022 -547,066.00
Mar 31, 2022 -1.49 Mn
Mar 31, 2022 -1.49 Mn
Dec 31, 2021 -1.11 Mn
Dec 31, 2021 -1.11 Mn
Sep 30, 2021 -50,759.00
Sep 30, 2021 -50,759.00
Jun 30, 2021 -158,008.00
Jun 30, 2021 -158,008.00
Mar 31, 2021 -266,446.00
Mar 31, 2021 -266,446.00